Hello and Welcome to Patientsville.com, Your Source for all JASMINE information. We are dedicated to provide You with JASMINE safety information. Learn about JASMINE serious adverse events reported to Food and Drug Administration (FDA).
Medications A-Z: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
JASMINE Safety Reports
Total JASMINE reports: 4.JASMINE FDA safety alerts: No.
Reported hospitalizations: 3.
Take JASMINE Side Effects Survey or Share Your JASMINE Story. Read More Here.
Health Professional from FRANCE reported JASMINE problem on June 21, 2007. Female patient, 28 years of age, weighting 94.80 lb, was diagnosed with oral contraception and was treated with JASMINE. After drug was administered, patient experienced the following problems/side effects: erythema nodosum, polyarthritis. JASMINE dosage: unknown. During the same period patient was treated with ZOLOFT, STRESAM, NOCTRAN. Patient was hospitalized. Patient recovered.
JASMINE problem was reported by a Physician from FRANCE on Aug 18, 2006. Female patient, 35 years of age, was diagnosed with oral contraception and was treated with JASMINE. After drug was administered, patient experienced the following problems/side effects: disease recurrence, myopia. JASMINE dosage: unknown. Patient recovered.
Physician from FRANCE reported JASMINE problem on Aug 28, 2006. Female patient, 23 years of age, weighting 119.0 lb, was diagnosed with oral contraception and was treated with JASMINE. After drug was administered, patient experienced the following problems/side effects: blood aldosterone increased, cellulitis, oedema peripheral, urine output decreased. JASMINE dosage: unknown. Patient was hospitalized. Patient recovered.
JASMINE problem was reported by a Health Professional from FRANCE on Sept 05, 2006. Female patient, 19 years of age, was diagnosed with oral contraception, viral infection and was treated with JASMINE. After drug was administered, patient experienced the following problems/side effects: asthenia, eosinophilia, myalgia, neutropenia, pyrexia, serum ferritin decreased, thrombocythaemia, viral infection. JASMINE dosage: unknown. During the same period patient was treated with IBUPROFEN. Patient was hospitalized. Patient recovered.